Tumour Hypoxia and Technetium Tracers: In Vivo Studies

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|5|2|99-105

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.5, Iss.2, 2012-04, pp. : 99-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and Biodistribution of Technetium-99m-Labeled Bis- Misonidazole (MISO) as an Imaging Agent for Tumour Hypoxia

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 649-655

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia signalling in tumour angiogenesis

By Knies U.E.   Harris A.L.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 361-375

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia PET Tracers in EBRT Dose Planning in Head and Neck Cancer

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 32-37

Bentham Science Publishers

Access to resources Recommend Favorite

Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

By Denny W.A.   Wilson W.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2889-2901

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, radiolabeling and stability of new nitrophenol complexes of Technetium-99m as possible hypoxia imaging radiopharmaceuticals

By Jalilian A.   Binehshmarvasti M.   Kumar P.   Wiebe L.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 9, 2006-09 ,pp. : 513-517

Springer Publishing Company

Access to resources Recommend Favorite